Navigation Links
United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
Date:9/10/2007

UBC ClinResearch to Expand Global Reach in Pioneering Field

BETHESDA, Md., Sept. 10 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the acquisition of an ownership interest in ClinResearch GmbH, a global leader in technology solutions and services for flexible, or adaptive, clinical trials. Headquartered in Cologne, Germany, with more than 100 employees, ClinResearch has designed and implemented 80 adaptive programs over the past seven years. ClinResearch's co-founder, Reinhard Eisebitt, is a co-developer of the leading software used by pharmaceutical companies and contract research organizations (CROs) throughout the world to support the rigorous statistical requirements of adaptive trials.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

ClinResearch, which will now operate under the name UBC ClinResearch, will be a centerpiece of UBC's adaptive design clinical trial offering and will deliver a full service, global solution for pharmaceutical, biotechnology and medical device companies seeking to capitalize on the benefits of adaptive design in their clinical development strategy.

"We are thrilled to welcome ClinResearch to the UBC family," said Ethan Leder, CEO of UBC. "Having worked with the founders for several years, we know that they are an excellent fit with our culture and vision. They are innovative and science driven, and have built a world-class organization with a track record of developing and executing technology solutions that we plan to introduce aggressively to our growing base of sponsor and CRO clients."

"The interest in adaptive design is accelerating from the early adopter to the rapid growth stage. We are excited to be joining an organization with the resources to allow us to capitalize on this opportunity," noted Michael Fischer, PhD, founder of ClinResearch. Fischer added, "We are moving forward with expansion plans to fulfill demand on our global projects with UBC and anticipate growth in Cologne, as well as in our offices in Russia and the Ukraine to benefit our clients."

According to Patrick Lindsay, Executive Vice President of UBC, "ClinResearch's leadership in adaptive design is consistent with UBC's focus on innovative solutions for clinical development. Reinhard Eisebitt, ClinResearch's co-founder, is recognized by the FDA and European regulatory authorities as a thought leader in adaptive design based on the proprietary software and techniques that he helped develop. We look forward to bringing our combined strengths in this novel and quickly evolving methodology to the industry." The ClinResearch announcement is the latest in a series of transactions made since UBC raised $153 million in equity capital from a syndicate of leading private equity firms in 2003.

Since 1999, ClinResearch, GmbH, headquartered in Cologne, Germany, has been a leader in planning, conducting and reporting clinical studies for the pharmaceutical and medical device industries. For more information, visit http://www.clinresearch.com.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.

CONTACT: Tess Drahzal, +1 (240) 644-0420, info@unitedbiosource.com


'/>"/>
SOURCE United BioSource Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Inacom Education earns Wisconsin membership in United Training
2. Fiserv acquires crime management software firm
3. GenTel acquires GlaxoSmithKline chip platform
4. Tushaus Computer acquires managed service business
5. RedPrairie acquires Denver software company
6. Eagle Technology acquires some synergy
7. Brady Corp. acquires Korean counterpart
8. Canadian firm acquires Silicon Logic
9. Imago acquires synergistic British firm
10. Fiserv acquires insurance, training product lines
11. Amazon acquires Madison-based Shopbop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... research firm Parks Associates announced today that Tom Kerber ... Annual Meeting , October 11 in Scottsdale, Arizona . ... how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... , ... October 09, 2017 , ... At its national ... Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has been ... a member of the winning team for the 2015 Breakthrough Prize in Fundamental physics ...
Breaking Biology Technology:
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):